GSI Seminar Series

A semimonthly series held on the first and third Tuesdays from 3:00-4:00pm in X 714-715 (unless otherwise noted).  The dual goals of this seminar series are to invite extramural speakers who are internationally recognized researchers at the vanguard of genetics and genomics research, and to sponsor intramural speakers in an effort to build interactions and collaborations among Boston University investigators engaged in genetics and genomics research.

To help increase the accessibility of the GSI Seminar Series, they will be broadcast online.  For more information please visit the Webinar Page.

If you would like to join the GSI Seminar Committee, have suggestions for invited speakers, or if you would like to present an intramural seminar, please email

For a list of past seminars, please visit the Past Seminars page.

To get more information, click on speakers name to link to their website.

Fall 2013 and Spring 2014

October 1

Targeted Next-Generation Sequencing Approaches for Rare Varient Discovery

Scott Leppanen, Ph.D.

Field Application Scientist
Agilent Technologies, Inc.

November 19

Mechanisms of genetic risk in chronic pancreatitis

Miklos Sahin-Toth, M.D., Ph.D.

Professor, Department of Molecular and Cell Biology,
Boston University
Henry M. Goldman School of Dental Medicine

December 11

(11:30AM– 12:30 PM in Keefer Auditorium)

lncRNAs:  Function and Mechanism in Controlling Cellular Identity

Mitchell Guttman, Ph.D.

Assistant Professor, Division of Biology and Biological Engineering
California Institute of Technology.

January 21

Topic: Predicting the functional impact of genetic variants obtained from high-throughput sequencing data

Daniel MacArthur, Ph.D.

Group Leader, Analytic and Translational Genetics Unit, MGH
Assistant Professor, Harvard Medical School
Research Affiliate, Broad Institute of Harvard and MIT

February 6

3-4pm in Keefer Auditorium, E111
Reception following in the Wilkins Board Room E120

Building a Biotech Company from the Ground Up: The Story of Regeneron

George Yancopoulos, M.D., Ph.D.

President, Regeneron Laboratories
Chief Scientific Officer, Regeneron Pharmaceuticals, Inc.
Member, National Academy of Sciences

March 4

Fishing for Effective Therapeutics for T-Lymphoblastic Leukemia

 Hui Feng M.D., Ph.D.

Assistant Professor
Department of Pharmacology & Experimental Therapeutics
Department of Medicine, Section of Hematology and Medical Oncology
Cancer Research Center
Boston University School of Medicine

March 10

(3-4 pm in Keefer Auditorium, E111)

Genome Engineering Using CRISPR-Cas9

Feng Zhang, Ph.D.

Assistant Professor, Department of Brain and Cognitive Sciences
McGovern Institute, MIT and Broad Institute of MIT and Harvard

May 6

Evolution and function of mammalian exons

(Note: to be held in L112)

Christopher Burge, Ph.D.

Professor of Biology and Biological Engineering
Director, Computational and Systems Biology Ph.D. Program
Massachusetts Institute of Technology

May 20

Topic: Identification of cis regulatory elements and gene regulatory networks

Martha L. Bulyk, Ph.D.

Associate Professor of Medicine and Pathology
Brigham & Women’s Hospital and Harvard Medical School